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http://dxObjective: Patients undergoing cardiac surgery are at risk for postoperative cognitive dysfunction (POCD).
Evaluating preoperative risk factors represents 1 possible way to minimize the postoperative risk of cognitive
dysfunction. We investigated marked deterioration in cholinergic neurotransmission as 1 such potential risk fac-
tor for transient and long-lasting POCD. Serum anticholinergic activity (SAA) has already been described as
a risk factor for developing delirium in an elderly study population. However, the role of SAA for long-
lasting POCD is unknown.
Methods: Following local ethics board approval and written informed consent, we recruited a cohort of patients
aged 55 years undergoing cardiac surgery. Before surgery, levels of SAAwere measured and a battery of neu-
ropsychologic tests (NPTs) was applied. S100 calcium binding protein ß concentration was measured intraoper-
atively. Pre-, intra-, and postoperative patient-specific characteristics were recorded. The NPTs were repeated
3 months after hospital discharge to evaluate 3-month POCD. A group of nonsurgical patients (n ¼ 34) was
recruited as control subjects to adjust NPT scores, using reliable methods for the change index. Logistic multi-
variate regression was used to evaluate independent predictors of POCD.
Results: One hundred fifty-four patients were screened before surgery, and 117 completed the second NPT.
POCD was identified in 25.6% of patients. In contrast to intraoperatively increased S100 calcium binding
protein ß, preoperative SAAwas not associated with POCD following adjustment for covariates.
Conclusions: Preoperatively increased SAA did not predict POCD 3 months after cardiac surgery. (J Thorac
Cardiovasc Surg 2013;145:805-11)P
MPostoperative cognitive dysfunction (POCD) affects differ-
ent domains of cognition, including verbal memory, lan-
guage comprehension, abstraction ability, attention, and
concentration,1 all of which show a high prevalence among
elderly persons2 and after cardiac surgery.3 In comparison
with postoperative delirium, cognitive decline due to
POCD persists longer, and recent studies have even investi-
gated if a long-lasting POCD increases the probability of
dementia onset.2
The underlying cause of POCD is unknown and
seems to be multifactorial. Therefore, many studies exist
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The Journal of Thoracic and Cafactors.3 However, a failure in cholinergic neurotrans-
mission4 is considered to be a central mechanism
underlying the development of delirium, POCD, and
dementia.
It is very laborious to directly detect cholinergic changes
in neurotransmission and this is also associated with sig-
nificant limitations in patients; therefore, measuring serum
anticholinergic activity (SAA) represents an alternative
technique for evaluating cerebral cholinergic transmis-
sion.5 The concept of an anticholinergic burden6,7
addresses a situation in which a variety of medications
inducing anticholinergic actions or endogenous factors
cause anticholinergic toxicity. Therefore, SAA reflects
the cumulative binding capacity of muscarinic receptors
in the blood to all drugs and their metabolites and can
be detected as being increased by a muscarinergic
anticholinergic radioreceptor assay independently of the
origin of the anticholinergic burden.
Previous studies suggested that there may be a link be-
tween cognitive deterioration and SAA.8 Recently, particu-
lar interest was directed to the anticholinergic burden in
patients undergoing surgery due to its possible relationship
with an increased risk of postoperative delirium.8 The role
of SAA for POCD, however, has not yet been investigated
to our knowledge.rdiovascular Surgery c Volume 145, Number 3 805
Abbreviations and Acronyms
ASA ¼ American Society of Anesthesiologists
BMI ¼ body mass index
CABG ¼ coronary artery bypass graft
CAM ¼ Confusion Assessment Method
ELISA ¼ enzyme-linked immunosorbent assay
HADS ¼ Hospital Anxiety Depression Scale
IQCODE ¼ Informant Questionnaire on Cognitive
Decline in the Elderly
NPT ¼ neuropsychologic tests
MMSE ¼ Mini-Mental State Examination
POCD ¼ postoperative cognitive dysfunction
RCI ¼ reliable change index
SAA ¼ serum anticholinergic activity
S100ß ¼ S100 calcium binding protein ß
SMC ¼ Subjective Memory Complaints
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P
MTherefore, the primary objective of our prospective study
was to evaluate the relationship between preoperative SAA
and 3-month POCD in a cohort of patients undergoing car-
diac surgery. Secondary objectives included investigating
other possible pre- or intraoperative risk factors that could
be related to POCD.MATERIALS AND METHODS
Study Population
Patients were recruited between June 2008 and September 2009 at the
Department of Cardiac Surgery, University of Heidelberg, Germany, after
receiving written informed consent. This clinical study was approved by
the appropriate local ethics committee and Institutional Review Board of
the University of Heidelberg and was performed in accordance with the
ethical standards of the Declaration of Helsinki. The study is registered
at http://www.clinicaltrials.gov (No. NCT00782938) and complies with
the strengthening of reporting of observational studies in epidemiology.
All patients aged  55 years admitted for elective cardiac surgery for
coronary artery bypass grafting (CABG) with or without aortic valve re-
placement surgery were recruited on the day before surgery. Patients sched-
uled for mitral valve surgery or for surgery of the carotid artery were not
included in this study. A total of 154 patients were screened. Before the op-
erative procedure, we used the Mini-Mental-State Examination (MMSE)
scale9 to screen for confusion and dementia. We excluded patients with
aMMSE score<25 points (n¼ 1); patients with depression (n¼ 2), schizo-
phrenia (n ¼ 2), or Parkinson’s disease (n ¼ 1); patients with a history of
alcohol or drug abuse (<4 weeks before hospital admission) (n ¼ 4);
patients with pronounced hearing or visual problems (n ¼ 2); non–Ger-
man-speaking people (n ¼ 2) (because the neuropsychologic test [NPT]
system is in German); and patients with red–green blindness (n ¼ 1).
Finally 139 patients were enrolled in the study; among them 117 completed
the postoperative NP testing, whereas 22 dropped out (7 died and 15 with-
drew). The following demographic information was recorded: age, sex,
height, body mass index (BMI), weight, and American Society of Anesthe-
siologists (ASA) status. Preoperative comorbidities were noted, and
preoperative medications with potential and known anticholinergic proper-
ties according to Lu and colleagues9 that had been administered continu-
ously for longer than 4 weeks before including patients in the our study
(long-term effect of medication) were documented. A blood sample806 The Journal of Thoracic and Cardiovascular Surg(2 mL venous blood) was drawn at the preoperative visit for preoperative
analysis of SAA.Intraoperative and Postoperative Procedures
Patients enrolled in this study received standard perioperative treatment
and care with regard to monitoring, anesthetic technique, and postoperative
analgesia. Blood was drawn 10 minutes before the end of surgery to ana-
lyze pH value, carbon dioxide tension, oxygen tension, bicarbonate, base
excess, hemoglobin, hematocrit, sodium, potassium, calcium, chloride,
glucose, lactate, and S100 calcium binding protein ß (S100ß). The length
of and time of extracorporeal circulation were recorded.
The prophylactic use of medication with anticholinergic action such as
scopolamine or meperidine was prohibited. Haloperidol was given only for
a maximum duration of 2 to 3 days in the hospital after a positive scoring
for delirium.
Postoperative data evaluation included duration of hospital stay, the
time between NPT settings, 3-month mortality, and delirium assessment.
Postoperative delirium was assessed by the same observer in the hospital
up to 7 days after surgery using the German version of the Confusion As-
sessment Method (CAM).10 The CAM poses 9 questions to an observer re-
garding the mental processes of patients being examined. Patients were
defined as delirium-positive if at least 1 of the CAM scorings was positive
once during their hospital stay.POCD Assessment
The MMSE was used to exclude patients with preexisting dementia
and applied before the first NPT. NPTs were compliant with the consen-
sus guidelines for cognitive testing following cardiac surgery analogous
to the International Study of Postoperative Cognitive Dysfunction
battery.1
The NPT was performed by 2 investigators. To optimize the reliability
of the NPT, both investigators were trained and audited periodically by
the same neuropsychologist (C.J.).
Memory capacity was evaluated using the revisedWechsler Adult Intel-
ligence Scale Digit Span11 (forward and backward) and we employed the
German verbal learning test12 based on Rey’s auditory verbal test for learn-
ing efficiency and memory consolidation.13 A list of 15 words had to be
learned in a consecutive presentation at a fixed rate (learning list). Patients
were asked to recall as many words as possible (word list: immediate and
delayed recall). The number of correctly and incorrectly recalled words
was recorded at 2 time points (recognition).
Psychomotor speed and dexterity, known to be sensitive indicators for
the presence of generalized brain dysfunction, was measured by the Trail
Making Test (A and B)14 and by the Digit Symbol Test.15 In addition,
the Stroop color word interference test16 was applied to measure selective
attention and concentration by recording time and number of errors.
Altogether 12 NPT variables were determined. We used a stopwatch for
all speed tests and participants were asked to work as fast and accurately as
possible. Two parallel versions were given in random tominimize any prac-
tice effect.
Anxiety and mood were assessed by the German version of the Hospital
Anxiety Depression Scale17,18 (HADS-D) at study entry and 3 months after
surgery. The HADS-D has 2 separate scales both ranging from 0 to 21, with
high scores corresponding to depression or anxiety and a cut-off score
of 11.
Subjective assessment of cognitive deterioration was evaluated at
the second visit using the German version of the Subjective Memory
Complaints (SMC) questionnaire.19 Participants were classified as patients
with subjective memory complaints if they responded positively to 1 of the
existing 5 questions. In addition, relatives completed the Informant Ques-
tionnaire on Cognitive Decline in the Elderly (IQCODE) short form20 as
a measure of cognitive change. With a mean IQCODE score>3.9 the
patients were classified as positive for cognitive decline.ery c March 2013
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MAll psychometric testing took place in quiet rooms in the hospital or at
home for about 45 minutes, and only the participant and the investigator
were present. The investigators who performed the tests were trained by
the psychologist responsible for developing the test battery (C.J.). Regular
site visits and supervision warranted standard collection of data and perfor-
mance of tests.
Control Group
Subjects for the control group without surgery were chosen to match
treatment patients’ age, sex, height, BMI, and preoperative illnesses from
a medical outpatient department. We ensured that control subjects had
comparable characteristics to the study group except surgery; therefore,
and for reasons of feasibility, we recruited 34 persons with a mean age
67.6 7.6 years and with the same proportion of men and women. All con-
trol subjects underwent NPT in the same way as the patients and none were
admitted to the hospital or dropped out.
POCD Data Analysis
The reliable change index (RCI) method—consistent with International
Study of Postoperative Cognitive Dysfunction methods1—was chosen to
characterize the presence or absence of 3-month POCD from the NPT bat-
tery of tests (International-RCI). To quantify the practice effect, we mea-
sured the average amount of change over time in NPT performance in
a cohort of nonsurgical volunteers (n ¼ 34). Then we compared changes
in performance among control subjects for each test from baseline (first
session) to 3 months after surgery.We calculated the mean and the standard
deviation of these differences. The mean changes were regarded as esti-
mated practice effects.
For patients, we compared baseline scores with 3-month test results,
subtracted the average practice effect from theses changes, and divided
the result by the control group standard deviation to obtain the z score
for each test. Large, positive z scores showed deterioration in cognitive
function from baseline in patients, whereas negative changes indicated
improvement.
We determined the z score for each test and a composite z score reflect-
ing an overall construct of POCD. A composite z score was calculated as
the sum of the z scores for an individual patient divided by the standard de-
viation for the sum of the z scores in the nonsurgical group. A patient was
classified as having POCD if the z score on either 2 individual tests or the
combined z score was1.96. This procedure identified patients with either
more general cognitive decline or with substantial deterioration in 2 or
more isolated domains of cognition.
Analysis of SAA and S100ß
SAA analysis was performed according to Lu and colleagues21 and as
previously described.5 In this SAA assay, anticholinergic agents in pa-
tients’ serum compete with tritiated quinuclidinyl benzilate for muscarinic
cholinergic receptors obtained from rat forebrain homogenate. The dis-
placement of 3[H]-quinuclidinyl benzilate was used to quantify the SAA
concentration compared with an atropine standard curve. Detection limit
was 0.5 pmol/mL, and samples were assessed as 1 batch. Intra-assay accu-
racy was between 92% and 103%, intra-assay precision was about 8%,
and interassay accuracy ranged between 96% and 106% (5 spiked serum
samples across 3 days at 5, 10, 25, and 50 pmol/mL).
To have an intraoperative parameter that is characterized as a potential
risk factor for postoperative deliriumwe included S100ß. S100ß concentra-
tion was determined according to the manufacturer’s instructions using
enzyme-linked immunosorbent assay (ELISA) technique (Abnova
GmbH, Heidelberg, Germany). This ELISA kit for determination of human
S100ß in serum sample is based on a sandwich enzyme immunoassay. Dur-
ing the first immune reaction, the human S100ß in standards or samples
binds to the rabbit antibovine S100ß antibodies, which are coated on the
surface of the microtitration plate. After rinsing out excess S100ß, labeledThe Journal of Thoracic and Caantibody (ie, biotinylated rabbit antibovine S100ß antibody) was added to
bind to the antigen-antibody complex. Then, excess labeled antibodies
were rinsed out and horseradish peroxidase labeled streptavidin were added
to bind to biotinylated rabbit antibovine S100ß. Finally, horseradish perox-
idase enzyme activity was determined and the concentration of S100ß was
calculated.
Statistical Analysis
It was not reasonable to calculate the exact sample size for testing the
preoperative SAA association to POCD in our explorative study because
no data were available in the literature concerning our hypothesis. How-
ever, this study was carried out under the following assumption: the prev-
alence of POCD after cardiac surgery is about 20%.22 Further, we assumed
a 10% loss during the 3-month follow-up period. Assuming a clinically im-
portant difference of 15% in SAA levels, about 100 patients were presum-
ably required for the study (a ¼ 0.05; 1-b ¼ 0.8). Under this condition,
a cohort of 100 patients would yield an 80% power to detect the aforemen-
tioned difference in SAA using a Wilcoxon test at the 5% level of
significance.
The Wilcoxon test, t test, and c2 test were applied as appropriate to
determine if baseline features and intra- and postoperative data differed
between patients with and without POCD.
Bivariate associations were explored using Spearman correlation and
linear regression analysis. The effect of risk factors potentially confound-
ing the relationship between SAA and S100ß and POCD was explored us-
ing logistic multivariate regression and presented as adjusted odds ratios
with 95% confidence intervals (CI) (P  .05). The statistical analyses
were performed using SPSS 19.0 (IBM, Armonk, NY) and SAS 9.1
(SAS Institute, Cary, NC).RESULTS
To evaluate the effect of learning for NPT, a control group
of 34 volunteers not undergoing surgery was enrolled in
whom demographic information (eg, age, sex, height,
weight, BMI, and preoperative anticholinergic medication)
matched that of the study group. The number of comorbid-
ities and the ASA status of the control group were lower
than in patients. Significantly lower SAA levels were deter-
mined in control subjects (1.6  1.7 pmol/mL) than in pa-
tients in the treatment group (4.5  3.9 pmol/mL). Higher
SAA levels correlated with a higher number of anticholin-
ergic medications (r ¼ 0.20; P ¼ .023). Therefore, we
hypothesized that higher SAA could be associated with re-
duced cognitive abilities. Linear regression analysis showed
a significant association (P ¼ .038); however, this effect is
not very pronounced and without clinical relevance because
of small r2 ¼ 0.03.
To evaluate POCD after cardiac surgery, 139 patients
were included in our study. The baseline cognition of pa-
tients who died or did not agree to complete the second
NPT (n ¼ 22) was not significantly different from patients
who had full NPT analysis (n ¼ 117).
POCD was found in 30 of 117 patients (25.6%). The
demographic characteristics and the comorbidities of
patients with and without POCD are shown in Table 1.
No significant differences between numbers of preoper-
ative anticholinergic medications and between SAA
was obtained between POCD positive (mean, 3.8; 95%rdiovascular Surgery c Volume 145, Number 3 807
TABLE 1. Demographic characteristics of patients, including comorbidities
No POCD (n ¼ 87) POCD (n ¼ 30) Total (n ¼ 117) P value
Sex
Woman 20 (23.0%) 8 (26.7%) 28 (23.9%) .684*
Man 67 (77.0%) 22 (73.3%) 89 (76.1%)
Age (y) 68.5  7.8 71.4  8.3 69.3  8.0 .082y
Body weight (kg) 80.9  11.8 86.9  16.7 82.5  13.4 .071y
Height (m) 1.75  0.12 1.72  0.15 1.73  0.11 .664y
Body mass index 27.9  4.0 29.8  4.8 28.4  4.3 .059y
ASA classification
Stage I-II: mild systemic disease 3 (3.6%) 0 (0.0%) 3 (2.6%) .574*
Stage III: severe systemic disease 78 (92.9%) 29 (96.7%) 107 (93.9%)
Stage IV: severe systemic disease that is a constant threat to life 3 (3.6%) 1 (3.3%) 4 (3.5%)
Comorbidities
Arterial hypertension 86 (98.9) 30 (100.0) 116 (99.1) .555*
Hypercholesterinemia 84 (96.6) 28 (93.3) 112 (95.7) .452*
Diabetes mellitus 26 (29.9) 14 (46.7) 40 (34.2) .095*
Obesity 22 (25.3) 12 (40.0) 34 (29.1) .126*
Renal insufficiency or nephropathy 71 (81.6) 23 (76.7) 94 (80.3) .557*
Cardiac arrhythmia 10 (11.5) 7 (23.3) 17 (14.5) .113*
Data are presented as number (%) or the mean standard deviation. POCD, Postoperative cognitive decline; ASA, American Society of Anesthesiologists. *Determined using c2
test. yDetermined using Wilcoxon test.
TABLE 2. Changes scores for neuropsychometric testing (NPT)
NPT Parameter
No POCD
(n ¼ 87)
POCD
(n ¼ 30)
P
value
Wechsler
memory scale
Digits forward 1.34  1.67 2.09  1.47 .05
Digits backward 0.52  0.97 0.73  1.53 .008
VLMT Learning ability 0.02  0.87 0.61  1.22 .017
Immediate recall 0.22  0.96 0.79  0.93 .001
Delayed recall 0.003  1.21 1.32  1.18 .001
Recognition 0.10  0.85 0.70  1.03 .023
Stroop test Word list 0.52  1.89 0.53  2.62 .09
Color list 0.26  1.65 1.04  2.30 .016
Interference list 0.13  1.14 0.92  0.42 .184
Trail making test A 0.16  1.19 0.54  1.95 .167
B 0.12  1.04 0.63  1.33 .152
Digit symbol test 0.66  1.11 0.77  1.09 .203
Data are expressed as corrected z scores standard deviation. Significant effects were
determined using t test. A score increase indicates deterioration. POCD, Postopera-
tive cognitive decline; VLMT, verbal learning and memory test; NPT, neuropsycho-
logic tests.
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Mconfidence interval, 1.5-5.0) and POCD negative (mean,
3.7; 95% confidence interval, 2.6-4.5) groups
(P ¼ .739).
All data were analyzed together because no significant
difference (P ¼ .222) in POCD diagnosis was detected
with respect to the type of surgery (CABG with [n ¼ 19]
and without aortic valve replacement [n ¼ 98]). Intraoper-
ative data showed no significant differences in duration of
surgery, extracorporal circulation, and arterial blood param-
eter (data not shown).
No significant differences between patients without and
with POCD were observed concerning the median duration
in hospital (median, 7.0 days; 25th quartile, 7.0 days; 75th
quartile 8.0 days vs median, 8.0 days; 25th quartile, 7.0
days; 25th quartile, 9.0 days) (P ¼ .128), or in the time pe-
riod between the first and the second NPT (median, 88.0
days; 25th quartile, 82.0 days; 75th quartile, 3.0 days vs me-
dian, 84.0 days; 25th quartile, 75.0 days; 75th quartile, 92.0
days) (P ¼ .530).
Postoperative delirium was found in 46 of 71 patients
(39%) in whom the CAM test could be conducted.
However, regression analysis did not show a significant
association of in-hospital delirium with a 3-month
POCD (P ¼ .165).
POCD diagnosis was summarized as corrected z score ac-
cording to the I-RCI. Significant deterioration in learning
and memory abilities was found in patients with POCD
compared with patients without POCD, and to a lesser ex-
tent, also in attention 3 months after surgery compared
with preoperative scoring results (Table 2). Interestingly,
patients with POCD were significantly more anxious and
depressed than patients without POCD (Figure 1).808 The Journal of Thoracic and Cardiovascular SurgAccording to postoperative SMC and IQCODE testing of
both the patients themselves and their relative, the results of
subjective and objective memory complaints analysis
showed a tendency for deterioration; however, no signifi-
cant changes were observed in patients with POCD com-
pared with patients without POCD (Table 3).
Results from risk factor analysis are presented in Table
4. Only the intraoperative parameter S100ß showed
a link (P ¼ .05) to POCD. In contrast, the preoperative
risk factor SAA was not associated with a higher inci-
dence of POCD. In addition, a patient’s age, sex, number
of anticholinergic medications with anticholinergic
side effect, and medical condition (ASA classification)ery c March 2013
FIGURE 1. Changes in (A) anxiety and (B) depression (represented as
median with 95% confidence interval) were determined using the Hospital
Anxiety Depression Scale and determined as differences between pre- and
postoperative scores. Significant deteriorations were determined in patients
with postoperative cognitive dysfunction (POCD) (1) compared with cog-
nitively unimpaired patients (0). *P<.05 based on Wilcoxon test.
TABLE 3. Postoperative assessment of cognitive changes by the
patients and their relatives
No POCD
(n ¼ 87)
POCD
(n ¼ 30)
Total
(n ¼ 117)
P
value*
IQCODE
No POCD 86 (98.9) 28 (93.3) 114 (97.4) .099
POCD 1 (1.1) 2 (6.7) 3 (2.6)
Subjective memory complaints
No POCD 76 (87.4) 22 (73.3) 98 (83.8) .073
POCD 11 (12.6) 8 (26.7) 19 (16.2)
Changes in cognitive abilities were determined 3 months after surgery by close
relatives using the Informant Questionnaire on Cognitive Decline in the Elderly
(IQCODE) and according to subjective memory complaints by the patients
themselves. No significant changes were determined. Data are presented as number
(%). POCD, Postoperative cognitive decline. *Based on c2 test.
TABLE 4. Analysis of risk factors, including P values and the adjusted
odds ratio (aOR) with 95% confidence interval (CI) for the major pre-,
intra-, and postoperative risk factors in relation to the postoperative
cognitive dysfunction diagnosis
Plaschke et al Perioperative Management
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Mrepresented no preoperative risk factors in our patient
population (P> .05).Possible risk factor P value aOR 95%Wald CI
SAA .347 0.932 0.804 1.080
Age .189 1.044 0.979 1.114
Sex .758 0.824 0.241 2.826
Anxiety .251 1.130 0.917 1.393
Depression .913 1.012 0.815 1.256
Anticholinergic medication .107 1.820 0.878 3.770
S100ß .050 1.001 1.000 1.002
Hemoglobin .692 0.951 0.740 1.222
Hematocrit .083 0.824 0.661 1.026
Postoperative delirium .443 0.680 0.254 1.823
SAA, Serum anticholinergic activity; S100ß, S100 calcium binding protein ß; aOR,
adjusted odds ratio; CI, confidence interval.DISCUSSION
POCD Incidence and NPT Results
The estimated incidence of POCD reaches 25% to 80%,
depending on the type of surgery, the definition of POCD,
and the time of postoperative assessment.1,23 For
example, longitudinal assessment of neurocognitive
function at 3 months showed that after noncardiac surgery
29% of middle-aged patients had symptoms of POCD.23
In addition, Newman and colleagues24 reported POCD in
24% of patients 6 months after CABG surgery. The inci-
dence of POCD of 24.6% 3 months after surgery, whichThe Journal of Thoracic and Cawas determined in our study, is therefore in agreement
with most data in the literature.
To determine POCD we used the I-RCI method1 with
a special focus on cardiac surgery patients3 and corrected
the data for the practice effect (control group). Our results
showed that differences in NPT were more pronounced
for memory abilities and less for attention and time-
dependent tasks. Therefore, memory is a more sensitive cat-
egory than attention and seems to be the first indicator of
persistent POCD.
In contrast to Johnson and colleagues,23 self-diagnosis of
POCD by the patient (SMC data) or by a close relative
(IQCODE data) did not show a marked decline in cognitive
abilities in our patient population 3 months after surgery.
The difference might be related to different patient collec-
tives: the mean age of our cardiac care patients was 69.3
 8.0 years in contrast to middle-aged patients after noncar-
diac surgery from the International Study of Postoperative
Cognitive Dysfunction investigation group.
Data from the literature show that POCD may be associ-
ated with depression.25 In fact, depression and anxiety were
significantly increased in our patient population (Figure 1),rdiovascular Surgery c Volume 145, Number 3 809
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mestic environment. The pathomechanism how CABG sur-
gery leads to depression is still unknown. However, surgical
stress may increase cortisol levels.26 According to our pre-
vious studies, increased glucocorticoid levels are associated
with cognitive decline.27 If cortisol levels are still increased
3 months after surgery due to a change in hypothalamic-
pituitary-adrenal axis regulation and if they are associated
with POCD is yet unknown. This constitutes a subject for
further research.
This prospective study has the following limitations: Sev-
eral factors might have influenced the validity of our con-
clusions. Of the 139 patients in whom baseline NPT was
performed, only 117 completed both follow-up tests. There-
fore, we cannot exclude that the results of our study may
have been biased by selective exclusion of those patients
with the greatest cognitive impairment or patients with
a higher grade of depression or anxiety.
Role of Risk Factors
Previous research has identified a high number of risk
factors affecting POCD.3,22 We included 10 potential risk
factors. All variables were tested for associations with
outcomes. We chose to limit the multiple testing, where
some of the significant findings could have occurred by
chance alone. Previous results suggest28 that determinants
of cognitive change after CABG surgery are both multifac-
torial and time-dependent and therefore difficult to com-
pare. In contrast to the aforementioned studies, we did not
find that demographic variables were associated with cogni-
tive changes. In our study, the patients had a mean age of 69
years. The standard deviation of  8.0 years was relatively
small. This might explain why we did not find the risk factor
age to be a predictor for POCD. Interestingly, we could not
confirm previous data29 that postoperative delirium de-
tected during a week of hospital stay was a significant pre-
dictor of POCD after 3 months, although it was found in
40% of patients. However, for practical reasons, we could
only score delirium in 71 patients; the limited number of pa-
tients might be the reason.
Serum markers of cerebral damage, such as the S100ß
protein, are used for diagnosis and prognosis of cognitive
function after cardiac surgery.30,31 A correlation between
neuropsychologic function and serum levels of S100ß
was found in patients after cardiac surgery; accordingly,
the International Study of Postoperative Cognitive
Dysfunction study group found significantly higher S100ß
levels in patients with POCD.30 However, several studies
have shown32 limited S100ß test applicability because of
poor correlation and sensitivity of these ELISA tests and
the apparent extracerebral sources for S100ß. The results
of our study, however, emphasize the role of intraoperative
S100ß as a potential predictor for POCD after cardiac sur-
gery with borderline values of significance (P ¼ .05).810 The Journal of Thoracic and Cardiovascular SurgTo our knowledge we are the first to investigate if preop-
erative SAA is a potential risk factor for POCD. Despite the
observation that SAA levels were 2.8-fold higher in patients
than in the control group without surgery and if the number
of anticholinergic medications is closely related to higher
SAA levels,20,33 no significant difference in SAA levels
was observed in patients developing a POCD compared
with patients without POCD. Logistic regression analysis
detected that SAA did not play a role as a preoperative
risk factor for persistent cognitive deterioration after
cardiac surgery in this study. Because only preoperative
SAA levels were included in our study, the significance of
this aspect is somewhat limited. Further studies will be
performed to address the correlation of postoperative
SAAwith 3-month POCD.
Indeed, the result regarding SAA is in accordance with
findings from previous studies on postoperative delirium
performed by our study group in patients in ICUs.32 In
addition, Marcantonio and colleagues34 failed to show
a correlation between the anticholinergic level and the
risk of postoperative delirium. However, our data are in
contrast to other reports.35 The reason for this difference
is still unclear, but might be associated with differences
in study population characteristics and medications.
Some anticholinergic medications that do not cross the
blood–brain barrier contribute to the results of an SAA
assay without necessarily having a corresponding cere-
bral effect, thus possibly weakening any relationship be-
tween SAA and cognitive performance in POCD.
Moreover, we defined strict exclusion criteria in our
study; therefore, only patients without psychiatric or neu-
rologic diseases and patients without a history of alcohol
or drug abuse were included. Thus, patients with poten-
tially higher SAAwere excluded to acquire a more homo-
geneous patient cohort. In our opinion, the age of patients
also plays a significant role: it has been shown that older
people have higher SAA levels.36 During aging, changes
in cerebral acetylcholine metabolism and in neurotrans-
mitter regulation have been demonstrated.37 However, it
was not possible to investigate the risk factor age in detail
using subgroup analysis for aging because our study was
performed in a monocentric way in a typical cardiac pa-
tient population.
On the other hand, endogenous sources of SAA related to
fever, acute infection, or stress have been postulated inde-
pendently of anticholinergic medication.7
Cortisol levels seem to play an important role for inter-
pretation of SAA. Therefore, higher cortisol concentrations
were associated with increased SAA levels.5,38 In chronic
states, the deleterious influence of high cortisol levels
leading to cognitive impairment is well documented.38
Like for other biomarkers, however, careful control of pa-
tient characteristics should be implemented, and further
studies will be required to investigate the importance ofery c March 2013
Plaschke et al Perioperative Managementhypercortisolism and the association to SAA as a biomarker
for POCD.
The authors thank Helmut Rauch, MD, Department of Anesthe-
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